RPS 2402 - Breast cancer staging and response to therapy
Lectures
1
Introduction by the moderator
04:00Mirjan Nadrljanski, Belgrade / RS
2
A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with low-grade ductal carcinoma in situ of the breast
08:00Daniela Ballerini, Pavia / IT
3
Diagnostic performance of imaging modalities for response of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis
08:00Thiemo van Nijnatten, Maastricht / NL
4
Prediction of primary tumour and axillary lymph node response to neoadjuvant systemic therapy with dedicated breast 18F-FDG PET/MRI in breast cancer
08:00Thiemo van Nijnatten, Maastricht / NL
5
Role of contrast-enhanced mammography (CEM) as a promising tool in preoperative staging of breast cancer
08:00Carlotta Rucci, Rome / IT
6
Preoperative staging of invasive lobular carcinoma (ILC): contrast-enhanced mammography (CEM) as alternative for breast MRI?
08:00Marc Lobbes, Sittard-Geleen / NL
7
The kinetic and morphologic changes of conventional and ultrafast dynamic contrast-enhanced MRI in breast cancer patients after neoadjuvant chemotherapy-preliminary report